Tag Archives: U.S.

Sagent buys U.S. sterile injectables plant in boost for parent Nichi-Iko

Japan’s Nichi-Iko Pharmaceutical bought Illinois-based Sagent Pharmaceuticals in 2016 to get a foothold in the U.S. Now Nichi-Iko is establishing a solid U.S. manufacturing footprint by acquiring a plant in North Carolina. Nichi-Iko says that Sagent has bought an FDA-approved small molecule and biologics manufacturing site in Raleigh from Copenhagen, Denmark-based Xellia Pharmaceuticals. The North… Read More »